Energy & Longevity Kit

Description

The Energy & Longevity Research Kit combines NAD⁺ (500mg), MOTS-c (40mg), and SG-1 (Semaglutide, 30mg) — addressing cellular energy metabolism, mitochondrial signaling, and GLP-1 receptor pathway biology within a single research panel targeting metabolic health and longevity-relevant pathways.

Kit Components

• NAD⁺ (500mg): Central cellular redox coenzyme and substrate for sirtuins (SIRT1–7) and PARPs. Declining NAD⁺ with age drives sirtuin deactivation, impaired DNA repair, and mitochondrial dysfunction — the focus of longevity research.
• MOTS-c (40mg): Mitochondria-derived retrograde signaling peptide activating AMPK and ARE/Nrf2 programs. Connects mitochondrial metabolic state to nuclear gene expression regulation.
• SG-1 / Semaglutide (30mg): GLP-1R agonist with extensively validated metabolic effects: glucagon suppression, insulin potentiation, POMC appetite regulation, and documented cardiovascular and renal protective effects in clinical trials.

Research Context

This kit spans cellular (NAD⁺, MOTS-c) and systemic (semaglutide) metabolic regulation. Researchers can investigate how improved systemic metabolic signaling (GLP-1R agonism) interacts with cellular energy optimization (NAD⁺ supplementation, MOTS-c-driven AMPK activation) — a question at the forefront of metabolic longevity research.

Common Research Applications

• Cellular energy + systemic metabolic regulation combination studies
• NAD⁺/MOTS-c/GLP-1 pathway interaction research
• Longevity-relevant metabolic pathway investigation
• AMPK-sirtuin-GLP-1 axis biology

For Research Use Only. Not for human or veterinary use.